SC 13G

SC-13G

Company: Protalix BioTherapeutics, Inc.
Filed: April 21, 2015
Accession Number: 0001178913-15-001281

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →

View Document ↗ View on SEC.gov ↗